Paolo Montuschi Selected Research

Paolo Montuschi Research Topics

Disease

43	Asthma (Bronchial Asthma) 04/2024 - 04/2002
21	Inflammation (Inflammations) 01/2023 - 04/2002
21	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2003
9	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023 - 05/2009
5	Lung Diseases (Lung Disease) 01/2017 - 10/2007
5	Pneumonia (Pneumonitis) 01/2013 - 04/2002
2	Hypersensitivity (Allergy) 01/2020 - 10/2002
2	Airway Remodeling 01/2019 - 08/2009
2	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 09/2008
2	Eosinophilia 06/2017 - 11/2016
2	Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome 11/2016 - 12/2014
2	Allergic Rhinitis 06/2016 - 05/2007
1	Eczema 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Sinusitis 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Respiratory Sounds (Crackle) 11/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2019
1	Body Weight (Weight, Body) 01/2018
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2018

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2007
18	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 07/2003
12	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 04/2002
11	8-epi-prostaglandin F2alphaIBA 01/2018 - 08/2002
10	LeukotrienesIBA 01/2021 - 04/2002
9	SteroidsIBA 01/2023 - 04/2002
8	Bronchodilator Agents (Bronchodilators)IBA 01/2020 - 01/2003
7	ProstaglandinsIBA 01/2021 - 04/2002
5	LipidsIBA 01/2023 - 05/2007
5	EicosanoidsIBA 01/2021 - 04/2002
4	Volatile Organic CompoundsIBA 04/2024 - 01/2013
4	Formoterol Fumarate (Oxis)FDA Link 01/2020 - 11/2016
4	Beclomethasone (Beclometasone)FDA Link 01/2020 - 08/2009
4	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2018 - 05/2015
4	vilanterolIBA 01/2018 - 05/2015
4	GSK573719IBA 01/2018 - 05/2015
4	Leukotriene B4IBA 08/2014 - 08/2002
3	Interleukin-13IBA 11/2023 - 03/2017
3	Leukotriene E4IBA 01/2021 - 08/2006
3	Dinoprostone (PGE2)FDA Link 01/2021 - 01/2016
3	SuspensionsIBA 01/2020 - 01/2011
3	fluticasone furoate FDA Link 01/2018 - 01/2016
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2016 - 01/2003
3	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 06/2010 - 05/2007
3	GlucocorticoidsIBA 06/2010 - 01/2003
3	Prostaglandins EIBA 08/2006 - 08/2002
2	Immunoglobulin E (IgE)IBA 01/2023 - 06/2017
2	dupilumabIBA 01/2022 - 03/2017
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Nitrogen DioxideIBA 09/2021 - 01/2020
2	Omalizumab (Xolair)FDA Link 01/2021 - 03/2017
2	Albuterol (Salbutamol)FDA LinkGeneric 01/2020 - 08/2009
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2020 - 01/2018
2	ProteomeIBA 01/2019 - 01/2018
2	Acetates (Acetic Acid Esters)FDA Link 01/2018 - 03/2013
2	AntioxidantsIBA 01/2018 - 01/2007
2	EnzymesIBA 01/2018 - 08/2002
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 11/2016 - 05/2015
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 12/2007 - 08/2006
2	montelukast (Singulair)FDA Link 12/2007 - 08/2006
2	Theophylline (Theon)FDA LinkGeneric 01/2006 - 01/2003
1	InflammasomesIBA 11/2023
1	AndrogensIBA 09/2023
1	Anabolic Androgenic SteroidsIBA 09/2023
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2023
1	AntigensIBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	tezepelumabIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	P-2 (P 2)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	fezakinumabIBA 01/2022
1	AmmoniaIBA 09/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	IsoprostanesIBA 01/2021
1	Prostaglandin D2IBA 01/2021
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 01/2020
1	Contrast MediaIBA 01/2020
1	Thromboxane B2IBA 11/2019
1	DefensinsIBA 11/2019
1	Interleukin-17 (Interleukin 17)IBA 11/2019
1	Interleukin-8 (Interleukin 8)IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	NitrogenIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2018
1	aclidinium bromideIBA 01/2018
1	Vitamin E FDA LinkGeneric 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018

Therapy/Procedure

12	Therapeutics 01/2022 - 10/2002
6	Drug Therapy (Chemotherapy) 01/2020 - 05/2002
5	Electronic Nose 01/2019 - 04/2010
2	Precision Medicine 01/2023 - 12/2014
2	Nebulizers and Vaporizers (Inhaler) 01/2018 - 01/2018
1	Biological Therapy 01/2022
1	Premedication 01/2020
1	Aftercare (After-Treatment) 01/2018